Efficient Cytotoxicity of Recombinant Azurin in
azurin
colon cancer
minicells
protein delivery
Journal
Bioengineering (Basel, Switzerland)
ISSN: 2306-5354
Titre abrégé: Bioengineering (Basel)
Pays: Switzerland
ID NLM: 101676056
Informations de publication
Date de publication:
13 Oct 2023
13 Oct 2023
Historique:
received:
26
05
2023
revised:
15
08
2023
accepted:
16
08
2023
medline:
28
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
Compared to chemical drugs, therapeutic proteins exhibit higher specificity and activity and are generally well-tolerated by the human body. However, the limitations, such as poor stability both in vivo and in vitro as well as difficulties in penetrating cell membranes, hinder their widespread application. To overcome the challenges, a highly efficient protocol was developed and implemented for the recombinant expression of the therapeutic protein azurin and secretion into minicells derived from probiotic
Identifiants
pubmed: 37892918
pii: bioengineering10101188
doi: 10.3390/bioengineering10101188
pmc: PMC10603951
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Natural Science Foundation of Guangdong Province
ID : 2022A1515010716
Organisme : Guangdong Key Areas R&D Program
ID : 2022B1111080007
Références
Proc Natl Acad Sci U S A. 1967 Feb;57(2):321-6
pubmed: 16591472
J Bacteriol. 1969 Aug;99(2):621-2
pubmed: 4897117
Cancer Res. 2009 Jan 15;69(2):537-46
pubmed: 19147567
Biomater Sci. 2016 Feb;4(2):205-18
pubmed: 26580477
J Bacteriol. 2002 Nov;184(21):5912-25
pubmed: 12374825
Theranostics. 2018 Feb 12;8(6):1690-1705
pubmed: 29556350
Cell Cycle. 2016 Jul 2;15(13):1665-6
pubmed: 27104624
Nat Biotechnol. 2009 Jul;27(7):643-51
pubmed: 19561595
Mol Pharm. 2008 Jan-Feb;5(1):92-7
pubmed: 18159928
Biochem Biophys Res Commun. 2005 Jul 15;332(4):965-8
pubmed: 15913547
Clin Cancer Res. 2005 Jul 1;11(13):4827-34
pubmed: 16000580
ACS Synth Biol. 2021 Oct 15;10(10):2465-2477
pubmed: 34516078
AAPS J. 2015 Jan;17(1):144-55
pubmed: 25398427
Adv Biochem Eng Biotechnol. 2008;111:1-66
pubmed: 18461293
ACS Nano. 2020 Oct 27;14(10):12972-12981
pubmed: 32997490
J Control Release. 2011 Feb 10;149(3):307-13
pubmed: 21047541
Pharmaceutics. 2023 Feb 17;15(2):
pubmed: 36840004
J Bacteriol. 1982 May;150(2):572-81
pubmed: 6175615
Int J Nanomedicine. 2011;6:3011-9
pubmed: 22162658
PLoS One. 2016 Apr 06;11(4):e0151832
pubmed: 27050167
J Bacteriol. 1980 Mar;141(3):1279-83
pubmed: 6767706
Nutr Rev. 2003 Mar;61(3):91-9
pubmed: 12723641
Br J Cancer. 2013 Jun 25;108(12):2495-504
pubmed: 23736031
Biochemistry. 2007 Feb 20;46(7):1799-810
pubmed: 17249693
J Clin Oncol. 2002 Jan 1;20(1):142-52
pubmed: 11773163
J Microbiol Methods. 2013 Mar;92(3):340-3
pubmed: 23234883
J Bacteriol. 2001 Oct;183(20):6144-7
pubmed: 11567016
Angiogenesis. 2011 Sep;14(3):355-69
pubmed: 21667138
J Bacteriol. 1970 Sep;103(3):836-9
pubmed: 4919994
Mol Biol Rep. 2019 Jun;46(3):3129-3140
pubmed: 30937652
Int J Biochem Cell Biol. 2018 Dec;105:123-133
pubmed: 30343150
ACS Synth Biol. 2021 Jun 18;10(6):1284-1291
pubmed: 34081866
Drug Deliv. 2013 Aug;20(6):237-46
pubmed: 23869787